Ocumetics Announces Optimized Lens Delivery System in Collaboration with Medicel

Executive Summary

• Medicel AG has further modified its intra‑ocular lens delivery system based on surgeon feedback from first‑in‑human implantations.
• The updated delivery platform improves loading efficiency, streamlines implantation, and is compatible with the mechanical properties of Ocumetics’ next‑generation accommodating IOL.
• Ocumetics plans to use the optimized system for its Group 2 surgeries scheduled for early 2026, supporting continued clinical advancement toward expanded trials and regulatory engagements.

Key Details

• Partner Collaboration: Medicel AG responded rapidly to surgeon input, refining the lens delivery technology used for the Ocumetrics Lens.
• Design Improvements: Enhancements target higher loading efficiency, smoother insertion, and better alignment with the unique mechanical characteristics of the Ocumetics accommodating intra‑ocular lens.
• Clinical Impact: The upgraded system is expected to increase surgeon acceptance and facilitate smoother procedures in upcoming Group 2 surgeries slated for early 2026.
• Future Plans: Ocumetrics intends to employ the optimized delivery platform throughout its next clinical stage, supporting expanded feasibility studies and preparation for regulatory submissions.

Notable Quotes

“The surgeon who performed our first‑in‑human implantations has been instrumental in shaping further improvements… Medicel’s willingness to innovate rapidly … demonstrates the strength of our partnership.” – Dean Burns, President & CEO, Ocumetics Technology Corp.